Can multiple myeloma result in urinary retention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

Yes, multiple myeloma can result in urinary retention in certain circumstances, particularly through spinal cord compression or hypercalcemia, which can impair kidney function and contribute to urinary problems. Multiple myeloma is a cancer of plasma cells that can lead to various complications affecting the urinary system. The most common way multiple myeloma causes urinary retention is through spinal cord compression, which occurs when myeloma lesions in the vertebrae press on the spinal cord, disrupting nerve signals to the bladder. Additionally, hypercalcemia (high calcium levels in the blood), a common complication of multiple myeloma, can impair kidney function and contribute to urinary problems 1. Myeloma patients may also develop amyloidosis, where abnormal protein deposits affect bladder function. Furthermore, some treatments for multiple myeloma, particularly certain chemotherapy agents, can cause neurological complications that affect bladder control.

Some key points to consider in the management of multiple myeloma-related urinary retention include:

  • Spinal cord compression requires urgent intervention, potentially including radiation therapy for spinal lesions 2
  • Hypercalcemia can be managed with medications to reduce calcium levels 3
  • Catheterization may be necessary for immediate relief of urinary retention
  • The association of the proteasome inhibitor Bortezomib and high dose Dexamethasone is the reference treatment in newly diagnosed patients with renal impairment 2
  • Collaboration between hematologists and nephrologists is essential throughout the course of the disease 2

Patients with multiple myeloma experiencing sudden urinary retention should seek immediate medical attention, as this could indicate spinal cord compression requiring urgent intervention. Management typically involves treating the underlying myeloma while addressing the specific cause of urinary retention. According to the most recent study 2, the management of multiple myeloma have to be adapted in patients with chronic kidney disease, dialysis or kidney transplantation. Because of improvement in global survival, kidney transplantation remains an option to consider in selected patients.

References

Related Questions

What is the treatment approach for a patient with multiple myeloma (MM) and nephrotic syndrome (NS)?
What is the relationship between multiple myeloma and proteinuria (presence of excess proteins in the urine)?
What is the difference between monoclonal and polyclonal hyperglobulinemia?
In a 63-year-old woman with a strong family history of multiple myeloma and normal complete blood count, comprehensive metabolic panel, and serum protein electrophoresis, should she undergo periodic re‑evaluation (e.g., annual labs) to monitor for multiple myeloma?
Which of the following causes of chronic renal failure typically does NOT present with enlarged kidneys: polycystic kidney disease, obstructive nephropathy, diabetic glomerulosclerosis, renovascular hypertension, or multiple myeloma?
What is the recommended management for a patient with bilateral basal atelectasis, punctate calcific densities in the liver, degenerative changes in the spine and joints, and gastrointestinal symptoms?
What is the clinical significance and management of low C4 (complement 4) levels?
What is the treatment for elevated C4 (complement component 4) levels?
What is the best treatment approach for gout in patients with hypertension?
What is the minimum age to administer 2-month vaccines, including DTaP (Diphtheria, Tetanus, and Pertussis), Hib (Haemophilus influenzae type b), PCV (Pneumococcal Conjugate Vaccine), and RV (Rotavirus Vaccine), in a child?
What is the management for bruising (ecchymosis) in patients taking minoxidil (Rogaine)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.